Blog

Registration

Powered by ChronoForms - ChronoEngine.com

Since clinical trials are extraordinarily expensive and addendum to ICH GCP E6 R2 recommends to “encourage implementation of improved and more efficient approaches to clinical trial design, conduct, oversight, recording and reporting”, as well as to use risk-based approach when planning the activities in clinical trials, industry must move forward and utilize efficient procedures in any possible area. One of the ways to optimize is shared audit.

Shared audit is an audit, conducted by several companies at one time through an independent auditing company.

  • Shared audit means shared costs.
  • Shared audit saves effort and time – you don’t have to send your QA person, break working processes and try to fit in another audit.
  • As an addition to the previous one, shared audit saves money on travel costs.
  • You can share an audit with any regulatory similar company – for example, works perfectly for the EU and the USA. It doesn’t even have to be only two companies – the number of participants is limited by you. By adding more participants, you save more money on the cost of the whole process.
  • Shared audits are no different from standard audits from a regulatory point of view, so there are no problems with further processing of its results. Remember the quote from the ICH in the first paragraph? Share audits are a perfect fit.
  • You can share not only an existing vendor audit but also a new vendor qualification.

And here’s a piece of experience:

Last year we had our first shared audit.

In our case, it was two of our clients, both EU based, so regulatory similar.  Before the actual audit started, both clients agreed on a contractor – independent auditing company, and an audit plan, based on their needs and requirements. As a vendor and the audit subject, Flex Databases received and used two audit plans: with similar content but separated to provide to every participant of the process. The audit took three full days, the process went smoothly, and the same way dozens of previous audits went.

After the audit, we’ve received two reports, that were reviewed by participating companies in accordance with their own requirements. And we’ll boast a little here – we got only a few corrections and comments. After we’ve implemented corrective and preventive actions, the process for us was complete.

If you want to know more about our experience with shared audits from a vendor perspective – send us a message to This email address is being protected from spambots. You need JavaScript enabled to view it..

If you’re looking for a new eClinical solutions vendor – here we are, audit and questions ready. Request a demo via the button on top of the page or drop us an email to This email address is being protected from spambots. You need JavaScript enabled to view it..

You may also be interested in
Categories
27 February 2019
10th Annual SCOPE Summit was held on 18 – 21 February in Orlando, Florida. If you have missed it for any reason, we are here to fill you in! Usually, all the insights we gather through an event are...
Good Clinical Practice is not only an industry standard - it is one of the core documents of our company, all of our modules are made in accordance with GCP. Interested? Request a demo via form on to...
A few months ago, I left my three years lasted marketing job in the automotive industry and started a new exciting journey at Flex Databases, that creates software for clinical trials. Hard start in t...
Looking for a pharmacovigilance software? Check our solution, request a demo or drop us an e-mail to bd@flexdatabases.com
Filters

Tags

DIABIOIPhEBCTMSEDCLMSe-CRFFDACROquizFlex JournalpharmacovigilanceinfographicGCPSCOPE

Powered by ChronoForms - ChronoEngine.com

Request Demo

Get in touch for a demo of our system. Fill in the form and we’ll contact you to demonstrate the system in action.

Powered by ChronoForms - ChronoEngine.com

Ваша заявка отправлена

Спасибо за Ваш интерес! Вы подписаны на нашу новостную рассылку.

Your request send

Thank you for your interest! You are subscribed to our newsletter